Ages: 18+

Study Description: This study is testing an investigational oral medication for atopic dermatitis, also known as eczema. Participants will receive one daily dose of either the study medication or a placebo for 16 weeks. Total participation will last approximately 6 months and would include 14 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost.

Qualifications:
- Must have been diagnosed with atopic derm for at least 1 year (and on 10% or more of your body***)
- Have documented reason why topical treatment was not medically recommended for you

Proof required for approval